Perrigo (NYSE:PRGO) is mainly a manufacturer of private-label OTC pharmaceuticals. It grew through a series of acquisitions and has a market cap of $10.7 billion, a PE of 20.93 and a dividend yield of 0.88 per cent. Guest Jean Pierre Verster from Fairtree Capital and resident expert Paul Theron from Vestact decide whether Perrigo is hot or not.